XML 47 R38.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stockholders' Equity (Details Textual)
 1 Months Ended 12 Months Ended
Nov. 30, 2015
USD ($)
Consultants
shares
Oct. 31, 2015
USD ($)
Consultants
$ / shares
shares
Jul. 31, 2015
USD ($)
shares
May. 31, 2015
USD ($)
shares
Sep. 30, 2014
USD ($)
Consultants
shares
Aug. 31, 2014
USD ($)
$ / shares
shares
Jan. 31, 2014
USD ($)
Consultants
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2014
USD ($)
shares
Dec. 31, 2013
shares
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Options exercisable intrinsic value               $ 33,605 $ 0  
Number of options exercisable | shares               11,025,273 10,335,000  
Number of Options | shares               11,025,273    
Stock-based compensation expense               $ 77,300 $ 45,000  
Common stock issued, value               $ (10,800)    
Company stock cancelled                  
Interest Expense               $ 37,476 $ 4,683  
Shareholder [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Option granted | shares     300,000              
Notes payable     $ 75,000         75,000    
Amount of note convert to company stock     $ 7,500         $ 85,200    
Common stock issued to shareholders | shares               441,177    
Options expiration period     3 years              
Investor [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Retired shares of common stock issued to investors, value       $ 10,800            
Retired shares of common stock issued to investors | shares       120,000            
Consultant [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Options expiration period   10 years                
Number of options, Granted | shares   110,000     450,000 300,000        
Weighted average exercise price, Granted | $ / shares   $ 0.20       $ 0.20        
Number of options, Granted value   $ 2,800       $ 8,000        
Stock-based compensation expense               $ 8,000    
Common stock issued, value $ 65,000                  
Common shares issued | shares 500,000                  
Stock option amortized service period           1 year        
Number of Options, Cancelled | shares 100,000                  
Company stock cancelled $ 28,000                  
Number of fully vested service-based options issued | shares 200,000                  
Number of consultant | Consultants 2 2     4   1      
Value of restricted shares issued to consultants         $ 52,500   $ 28,000      
Restricted shares issued to consultants, shares | shares         525,000   100,000      
Minimum [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Annual sales revenue target               2,000,000    
Maximum [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Annual sales revenue target               $ 100,000,000    
Performance Based Stock Options [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Number of options, Granted | shares               9,305,000    
Number of Options | shares                 300,000  
Stock-based compensation expense               $ 142,300 $ 125,500  
Unearned share based compensation               333,700    
Compensation and related expenses               133,800 $ 125,500  
Interest Expense               $ 8,500    
Performance Based Stock Options [Member] | Minimum [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Weighted average exercise price, Granted | $ / shares               $ 0.20    
Annual sales revenue target               $ 2,000,000    
Performance Based Stock Options [Member] | Maximum [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Weighted average exercise price, Granted | $ / shares               $ 5.00    
Annual sales revenue target               $ 100,000,000    
Employee Stock Option [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Number of options, Granted | shares               790,273 450,000  
Number of Options | shares               11,025,273 10,435,000 9,985,000
Stock-based compensation expense               $ 22,300 $ 17,500  
Number of Options, Cancelled | shares               200,000    
Number of shares expiration in period | shares                 500,000  
Warrant [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Options expiration period                 1 year  
Number of shares expiration in period | shares                 1,500,000  
Director [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Option granted | shares               40,800    
Notes payable               $ 10,200    
Amount of note convert to company stock               $ 1,000    
Common stock issued to shareholders | shares               60,000    
Options expiration period               3 years    
Number of options, Granted | shares         450,000          
Director [Member] | Employee Stock Option [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Options expiration period               1 year    
Number of shares expiration in period | shares               500,000    
Fair value of warrants               $ 55,000    
President [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Options expiration period               3 years    
Number of options, Granted | shares               339,473    
Weighted average exercise price, Granted | $ / shares               $ 0.10    
Number of options, Granted value               $ 13,000    
Common shares issued | shares               449,225    
Royalties payable               $ 84,868    
President [Member] | Warrant [Member]                    
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                    
Options expiration period               2 years    
Number of shares expiration in period | shares               1,500,000    
Fair value of warrants               $ 55,000